Phosphoproteomic analysis of SW48 CRC cells revealed that KRASG12D and KRASG13D mutations led to increased tyrosine phosphorylation, including the activation of MAPK and AKT pathways, compared to WT KRAS cells. The gene discussed is KRAS; the disease is colorectal carcinoma.